Skip to content
PICO Portalanswers from OpenAlex

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates

PaperCitations, authors & open-access status

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates is a paper indexed in PICO Portal from OpenAlex.

How many citations does Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates have?

PICO Portalcitation count

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates has 1,417 citations in the OpenAlex counts PICO Portal stores.

When was Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates published?

PICO Portalyear

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates has 2018 year in the PICO Portal index.

What is the open-access status of Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates?

PICO Portaloa status

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates has closed oa status in the PICO Portal index.

What is the DOI of Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates?

PICO Portaldoi

The DOI for Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates is on the source record.

What is the PMID of Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates?

PICO Portalpmid

The PMID for Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates is on the source record.

What is the OpenAlex record for Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates?

PICO Portalopenalex

The OpenAlex for Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial